PetGeneX Wins International Recognition at iENA 2025 in Germany
PetGeneX Wins International Recognition at iENA 2025 in Germany
PetGeneX (Innovative Science for Pet Co., Ltd.),
a biotechnology startup from Thailand, has been awarded the Best Selected Inventions honor by the China Association of Inventions (CAI) at iENA 2025 – International Trade Fair for Ideas, Inventions & New Products, held in Nuremberg, Germany.
The award recognizes PetGeneX’s innovative research titled:
“Stem Cell Innovation for the Isolation and Expansion of Peripheral Blood-Derived Mesenchymal Stem Cells from Pets.”
This technology represents a significant advancement in the field of Regenerative Veterinary Medicine, focusing on stem cell isolation and expansion from the peripheral blood of companion animals.
From Thailand to the Global Innovation Stage
iENA is one of Europe’s most important international exhibitions for innovation and inventions, bringing together researchers, inventors, and technology-driven organizations from more than 30 countries worldwide.
PetGeneX’s recognition at iENA 2025 reflects the growing potential of Thai biotechnology research and its ability to meet international standards in scientific innovation and applied life sciences.
Pet Stem Cell Innovation Developed by a Thai Research Team
The awarded innovation was developed by a Thai research team under the concept of using autologous cells, derived from the pet’s own peripheral blood.
This approach aims to support future applications in long-term pet health management while minimizing invasiveness and aligning with scientific and ethical standards.
The technology highlights a new direction in pet stem cell research and contributes to the global advancement of regenerative veterinary science.
A Milestone for Regenerative Veterinary Medicine in Asia
This international recognition marks an important milestone not only for PetGeneX, but also for the broader development of Regenerative Veterinary Medicine in Asia.
PetGeneX remains committed to advancing knowledge and innovation in pet stem cell biotechnology, with the goal of supporting sustainable and science-driven approaches to pet healthcare on both regional and global levels.
A Source of Pride for Thai Innovation
The award represents more than an organizational achievement. It reflects the growth of Thailand’s biotechnology innovation ecosystem and its increasing presence on the global stage.
PetGeneX continues to invest in research and innovation to support the long-term future of pet health and to contribute meaningfully to the international scientific community.
About PetGeneX
PetGeneX (Innovative Science for Pet Co., Ltd.)
is a Thailand-based biotechnology company dedicated to developing solutions for pet stem cell management and cell expansion technologies. The company focuses on supporting future pet healthcare through scientific excellence, ethical standards, and responsible innovation.
Investing in Health Today is an Investment in Your Pet's Future
The year 2026 may bring new challenges for pet health, but with information, knowledge, and advanced technology like
PetGeneX, every pet owner can be prepared and handle various situations effectively.
Pet health care is not limited to treating illnesses but is a proactive approach that starts with prevention, planning, and leveraging medical innovations to ensure your beloved pet lives a long, healthy, and happy life with you.
Tell: 062-426-4145
Line: @petgenex
Website: www.petgenex-thailand.com
